Graviton BioScience has filed a notice of an exempt offering of securities to raise $24,999,996.00 in New Equity Investment.
According to filings with the U.S. Securities and Exchange Commission, Graviton BioScience is raising up to $24,999,996.00 in new funding. Sources indicate that as part of senior management Chief Executive Officer, Samuel Waksal played a…